Physician profile
Michael Lin
NPI 1063705309
$500.15
in general payments reported to CMS, 2019-2025
7 companies · $59.11 in 2025
The $59.11 reported for 2025 was less than what a typical Transplant Hepatology provider received nationally (typical 2025 total: $508).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $27.95 · 2022: $119 · 2024: $57.78 · 2025: $59.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $116.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $146.48 | 2020-2022 | |
| Gilead Sciences, INC. | $145.49 | 2019-2024 | Livdelzi |
| Boston Scientific Corporation | $119.05 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $32.00 | 2025 | Iqirvo |
| Revance Therapeutics, INC. | $27.11 | 2025 | Daxxify |
| Foundation Medicine, INC. | $15.05 | 2019 | |
| Shionogi INC | $14.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.